{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,15]],"date-time":"2025-12-15T00:31:22Z","timestamp":1765758682573},"reference-count":29,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,12,17]],"date-time":"2022-12-17T00:00:00Z","timestamp":1671235200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,12,17]],"date-time":"2022-12-17T00:00:00Z","timestamp":1671235200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Pregnancy Childbirth"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Plenty of studies explored the most optimal treatment protocol for infertile women with adenomyosis in in-vitro fertilization (IVF) \/intracytoplasmic sperm injection (ICSI), however, there is still no consensus on which treatment protocol is ideal for these women at present. So, we conducted this study comparing the pregnancy outcomes in infertile women with ultrasound-diagnosed adenomyosis who underwent GnRH antagonist protocol with freeze-all strategy or long-acting GnRH agonist protocol.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>This was a retrospective cohort study and a propensity-score matching (PSM) analysis including 282 women diagnosed with adenomyosis undergoing their first IVF\/ICSI cycle from January 2016 to July 2021 at the Assisted Reproduction Center, Northwest Women\u2019s and Children\u2019s Hospital, China. The patients were divided into two groups: the GnRH antagonist protocol with freeze-all strategy (<jats:italic>n<\/jats:italic>\u2009=\u2009168) and the long-acting GnRH agonist protocol with fresh embryo transfer (<jats:italic>n<\/jats:italic>\u2009=\u2009114) according their treatment protocols. The primary outcome was live birth rate. Cumulative live birth rate was also calculated.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>After adjusting for confounders, clinical pregnancy rate (49.40% vs 64.04%; odds ratio (OR) 1.33; 95% confidence interval (CI) 0.70 to 2.37; <jats:italic>P<\/jats:italic>\u2009=\u20090.358), live birth rate (36.90% vs 45.61%; OR 1.10; 95% CI 0.61 to 2.00, <jats:italic>P<\/jats:italic>\u2009=\u20090.753) and cumulative live birth rate (51.79% vs 64.04%; OR 1.01; 95% CI 0.49 to 1.74, <jats:italic>P<\/jats:italic>\u2009=\u20090.796) were not significantly different between the GnRH antagonist protocol with freeze-all strategy and long-acting GnRH agonist protocol. Similar results were conducted in PSM analysis with clinical pregnancy rate (46.48% vs 60.56%; OR 1.33; 95% CI 0.76 to 2.34; <jats:italic>P<\/jats:italic>\u2009=\u20090.321), live birth rate (32.39% vs 45.07%; OR 1.31; 95% CI 0.63 to 2.72, <jats:italic>P<\/jats:italic>\u2009=\u20090.463) and cumulative live birth rate (54.90% vs 60.60%; OR 1.01; 95% CI 0.59 to 1.74, <jats:italic>P<\/jats:italic>\u2009=\u20090.958).<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>For infertile women with adenomyosis, these two treatment protocols resulted in similar pregnancy outcomes. Larger, prospective studies are needed in the future.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12884-022-05276-9","type":"journal-article","created":{"date-parts":[[2022,12,17]],"date-time":"2022-12-17T11:03:44Z","timestamp":1671275024000},"update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Comparison of pregnancy outcomes between GnRH antagonist protocol with freeze-all strategy and long-acting GnRH agonist protocol in women with adenomyosis undergoing IVF\/ICSI: a propensity-score matching analysis"],"prefix":"10.1186","volume":"22","author":[{"given":"Liting","family":"Zhang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"He","family":"Cai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xitong","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yao","family":"Xiong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaoling","family":"Liang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Juanzi","family":"Shi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2022,12,17]]},"reference":[{"key":"5276_CR1","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1016\/j.rbmo.2011.10.003","volume":"24","author":"S Campo","year":"2012","unstructured":"Campo S, Campo V, Benagiano G. Adenomyosis and infertility. Reprod BioMed Online. 2012;24:35\u201346.","journal-title":"Reprod BioMed Online"},{"key":"5276_CR2","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1016\/j.bpobgyn.2018.01.013","volume":"51","author":"T Van den Bosch","year":"2018","unstructured":"Van den Bosch T, Van Schoubroeck D. Ultrasound diagnosis of endometriosis and adenomyosis: state of the art. Best Pract Res Clin Obstet Gynaecol. 2018;51:16\u201324.","journal-title":"Best Pract Res Clin Obstet Gynaecol"},{"key":"5276_CR3","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1016\/j.fertnstert.2018.01.024","volume":"109","author":"M Bazot","year":"2018","unstructured":"Bazot M, Dara\u00ef E. Role of transvaginal sonography and magnetic resonance imaging in the diagnosis of uterine adenomyosis. Fertil Steril. 2018;109:389\u201397.","journal-title":"Fertil Steril"},{"key":"5276_CR4","doi-asserted-by":"publisher","unstructured":"Cozzolino M, Tartaglia S, Pellegrini L, Troiano G, Rizzo G, Petraglia F. The effect of uterine Adenomyosis on IVF outcomes: a systematic review and Meta-analysis. Reprod Sci. 2022. https:\/\/doi.org\/10.1007\/s43032-021-00818-6.","DOI":"10.1007\/s43032-021-00818-6"},{"key":"5276_CR5","doi-asserted-by":"crossref","unstructured":"Squillace ALA, Simonian DS, Allegro MC, J\u00fanior EB, Bianchi PH de M, Bibancos M. Adenomyosis and in vitro fertilization impacts-a literature review. JBRA Assist Reprod 2021;25:303\u2013309.","DOI":"10.5935\/1518-0557.20200104"},{"key":"5276_CR6","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1093\/hropen\/hoab015","volume":"2021","author":"C Higgins","year":"2021","unstructured":"Higgins C, Fernandes H, Da Silva CF, Martins WP, Vollenhoven B, Healey M. The impact of adenomyosis on IVF outcomes: a prospective cohort study. Hum Reprod Open. 2021;2021:1\u201310.","journal-title":"Hum Reprod Open"},{"key":"5276_CR7","doi-asserted-by":"publisher","first-page":"592","DOI":"10.1093\/humupd\/dmz012","volume":"25","author":"J Horton","year":"2019","unstructured":"Horton J, Sterrenburg M, Lane S, Maheshwari A, Li TC, Cheong Y. Reproductive, obstetric, and perinatal outcomes of women with adenomyosis and endometriosis: a systematic review and meta-analysis. Hum Reprod Update. 2019;25:592\u2013632.","journal-title":"Hum Reprod Update"},{"key":"5276_CR8","doi-asserted-by":"publisher","first-page":"964","DOI":"10.1093\/humrep\/deu041","volume":"29","author":"P Vercellini","year":"2014","unstructured":"Vercellini P, Consonni D, Dridi D, Bracco B, Frattaruolo MP, Somigliana E. Uterine adenomyosis and in vitro fertilization outcome: A systematic review and meta-analysis. Hum Reprod. 2014;29:964\u201377.","journal-title":"Hum Reprod"},{"key":"5276_CR9","doi-asserted-by":"crossref","unstructured":"Lan J, Wu Y, Wu Z, Wu Y, Yang R, Liu Y, et al. Ultra-Long GnRH Agonist Protocol During IVF\/ICSI Improves Pregnancy Outcomes in Women With Adenomyosis: A Retrospective Cohort Study. Front Endocrinol (Lausanne). 2021:495.","DOI":"10.3389\/fendo.2021.609771"},{"key":"5276_CR10","doi-asserted-by":"publisher","first-page":"845","DOI":"10.1016\/j.rbmo.2020.07.027","volume":"41","author":"X Hou","year":"2020","unstructured":"Hou X, Xing J, Shan H, Mei J, Sun Y, Yan G, et al. The effect of adenomyosis on IVF after long or ultra-long GnRH agonist treatment. Reprod BioMed Online. 2020;41:845\u201353.","journal-title":"Reprod BioMed Online"},{"key":"5276_CR11","doi-asserted-by":"publisher","first-page":"735","DOI":"10.1016\/S0015-0282(02)04813-6","volume":"79","author":"H Ishihara","year":"2003","unstructured":"Ishihara H, Kitawaki J, Kado N, Koshiba H, Fushiki S, Honjo H. Gonadotropin-releasing hormone agonist and danazol normalize aromatase cytochrome P450 expression in eutopic endometrium from women with endometriosis, adenomyosis, or leiomyomas. Fertil Steril. 2003;79:735\u201342.","journal-title":"Fertil Steril"},{"key":"5276_CR12","doi-asserted-by":"publisher","first-page":"828","DOI":"10.1016\/j.fertnstert.2019.12.018","volume":"113","author":"A Kaponis","year":"2020","unstructured":"Kaponis A, Chatzopoulos G, Paschopoulos M, Georgiou I, Paraskevaidis V, Zikopoulos K, et al. Ultralong administration of gonadotropin-releasing hormone agonists before in vitro fertilization improves fertilization rate but not clinical pregnancy rate in women with mild endometriosis: a prospective, randomized, controlled trial. Fertil Steril. 2020;113:828\u201335.","journal-title":"Fertil Steril"},{"key":"5276_CR13","doi-asserted-by":"publisher","first-page":"1621","DOI":"10.2147\/DDDT.S162541","volume":"12","author":"S Guo","year":"2018","unstructured":"Guo S, Li Z, Yan L, Sun Y, Feng Y. GnRH agonist improves pregnancy outcome in mice with induced adenomyosis by restoring endometrial receptivity. Drug Des Devel Ther. 2018;12:1621\u201331.","journal-title":"Drug Des Devel Ther"},{"key":"5276_CR14","doi-asserted-by":"publisher","first-page":"2676","DOI":"10.1093\/humrep\/deab163","volume":"36","author":"C Tomassetti","year":"2021","unstructured":"Tomassetti C, Beukeleirs T, Conforti A, Debrock S, Peeraer K, Meuleman C, et al. The ultra-long study: a randomized controlled trial evaluating long-term GnRH downregulation prior to ART in women with endometriosis. Hum Reprod. 2021;36:2676\u201386.","journal-title":"Hum Reprod"},{"key":"5276_CR15","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12958-021-00814-0","volume":"19","author":"J Yang","year":"2021","unstructured":"Yang J, Zhang X, Ding X, Wang Y, Huang G, Ye H. Cumulative live birth rates between GnRH-agonist long and GnRH-antagonist protocol in one ART cycle when all embryos transferred: real-word data of 18,853 women from China. Reprod Biol Endocrinol. 2021;19:1\u20139.","journal-title":"Reprod Biol Endocrinol"},{"key":"5276_CR16","doi-asserted-by":"publisher","first-page":"S39","DOI":"10.1016\/S0015-0282(01)02133-1","volume":"76","author":"D Valbuena","year":"2001","unstructured":"Valbuena D, Martin JC, De Pablo JL, Remohi J, Pellicer A, Sim\u00f3n C. Increasing levels of estradiol are deleterious to embryonic implantation due mainly to a direct effect on the embryo. Fertil Steril. 2001;76:S39.","journal-title":"Fertil Steril"},{"key":"5276_CR17","doi-asserted-by":"publisher","first-page":"523","DOI":"10.1056\/NEJMoa1513873","volume":"375","author":"Z-J Chen","year":"2016","unstructured":"Chen Z-J, Shi Y, Sun Y, Zhang B, Liang X, Cao Y, et al. Fresh versus frozen embryos for infertility in the polycystic ovary syndrome. N Engl J Med. 2016;375:523\u201333.","journal-title":"N Engl J Med"},{"key":"5276_CR18","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1056\/NEJMoa1705334","volume":"378","author":"Y Shi","year":"2018","unstructured":"Shi Y, Sun Y, Hao C, Zhang H, Wei D, Zhang Y, et al. Transfer of fresh versus frozen embryos in ovulatory women. N Engl J Med. 2018;378:126\u201336.","journal-title":"N Engl J Med"},{"key":"5276_CR19","doi-asserted-by":"publisher","first-page":"1023","DOI":"10.1016\/j.rbmo.2022.02.013","volume":"44","author":"X Zhu","year":"2022","unstructured":"Zhu X, Dongye H, Lu S, Zhao X, Yan L. Pregnancy outcomes after fresh versus vitrified-warmed embryo transfer in women with adenomyosis: a retrospective cohort study. Reprod BioMed Online. 2022;44:1023\u20139.","journal-title":"Reprod BioMed Online"},{"key":"5276_CR20","doi-asserted-by":"publisher","first-page":"1576","DOI":"10.1148\/rg.2018180080","volume":"38","author":"RK Cunningham","year":"2018","unstructured":"Cunningham RK, Horrow MM, Smith RJ, Springer J. Adenomyosis: A sonographic diagnosis. Radiographics. 2018;38:1576\u201389.","journal-title":"Radiographics."},{"key":"5276_CR21","doi-asserted-by":"publisher","first-page":"1130","DOI":"10.1093\/humrep\/des004","volume":"27","author":"RL Odonnell","year":"2012","unstructured":"Odonnell RL, Warner P, Lee RJ, Walker J, Bath LE, Kelnar CJ, et al. Physiological sex steroid replacement in premature ovarian failure: randomized crossover trial of effect on uterine volume, endometrial thickness and blood flow, compared with a standard regimen. Hum Reprod. 2012;27:1130\u20138.","journal-title":"Hum Reprod"},{"key":"5276_CR22","doi-asserted-by":"publisher","first-page":"480","DOI":"10.1177\/1933719118756754","volume":"25","author":"TP Rocha","year":"2018","unstructured":"Rocha TP, Andres MP, Borrelli GM, Abr\u00e3o MS. Fertility-sparing treatment of Adenomyosis in patients with infertility: A systematic review of current options. Reprod Sci. 2018;25:480\u20136.","journal-title":"Reprod Sci"},{"key":"5276_CR23","doi-asserted-by":"publisher","first-page":"3487","DOI":"10.1093\/humrep\/des305","volume":"27","author":"V Thalluri","year":"2012","unstructured":"Thalluri V, Tremellen KP. Ultrasound diagnosed adenomyosis has a negative impact on successful implantation following GnRH antagonist IVF treatment. Hum Reprod. 2012;27:3487\u201392.","journal-title":"Hum Reprod"},{"key":"5276_CR24","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1159\/000501204","volume":"85","author":"X Ma","year":"2020","unstructured":"Ma X, Du W, Hu J, Yang Y, Zhang X. Effect of gonadotrophin-releasing hormone agonist addition for luteal support on pregnancy outcome in vitro fertilization\/intracytoplasmic sperm injection cycles: A Meta-analysis based on randomized controlled trials. Gynecol Obstet Investig. 2020;85:13\u201325.","journal-title":"Gynecol Obstet Investig"},{"key":"5276_CR25","doi-asserted-by":"publisher","first-page":"1026","DOI":"10.3109\/09513590.2013.824960","volume":"29","author":"Z Niu","year":"2013","unstructured":"Niu Z, Chen Q, Sun Y, Feng Y. Long-term pituitary downregulation before frozen embryo transfer could improve pregnancy outcomes in women with adenomyosis. Gynecol Endocrinol. 2013;29:1026\u201330.","journal-title":"Gynecol Endocrinol"},{"key":"5276_CR26","doi-asserted-by":"publisher","first-page":"380","DOI":"10.1016\/j.rbmo.2021.10.014","volume":"44","author":"Y Wu","year":"2022","unstructured":"Wu Y, Huang J, Zhong G, Lan J, Lin H, Zhang Q. Long-term GnRH agonist pretreatment before frozen embryo transfer improves pregnancy outcomes in women with adenomyosis. Reprod BioMed Online. 2022;44:380\u20138.","journal-title":"Reprod BioMed Online"},{"key":"5276_CR27","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41598-020-79139-8","volume":"11","author":"M Li","year":"2021","unstructured":"Li M, Xu L, Zhao H, Du Y, Yan L. Effects of artificial cycles with and without gonadotropin-releasing hormone agonist pretreatment on frozen embryo transfer outcomes in patients with adenomyosis. Sci Rep. 2021;11:1\u20138.","journal-title":"Sci Rep"},{"key":"5276_CR28","doi-asserted-by":"publisher","first-page":"384","DOI":"10.1016\/j.rbmo.2020.10.002","volume":"42","author":"X Li","year":"2021","unstructured":"Li X, Pan N, Zhang W, Wang Y, Ge Y, Wei H, et al. Association between uterine volume and pregnancy outcomes in adenomyosis patients undergoing frozen-thawed embryo transfer. Reprod BioMed Online. 2021;42:384\u20139.","journal-title":"Reprod BioMed Online"},{"key":"5276_CR29","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12958-021-00764-7","volume":"19","author":"T Iwasawa","year":"2021","unstructured":"Iwasawa T, Takahashi T, Maeda E, Ishiyama K, Takahashi S, Suganuma R, et al. Effects of localisation of uterine adenomyosis on outcome of in vitro fertilisation\/intracytoplasmic sperm injection fresh and frozen-thawed embryo transfer cycles: a multicentre retrospective cohort study. Reprod Biol Endocrinol. 2021;19:1\u201311.","journal-title":"Reprod Biol Endocrinol"}],"container-title":["BMC Pregnancy and Childbirth"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12884-022-05276-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12884-022-05276-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12884-022-05276-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,17]],"date-time":"2022-12-17T11:03:55Z","timestamp":1671275035000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcpregnancychildbirth.biomedcentral.com\/articles\/10.1186\/s12884-022-05276-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,12,17]]},"references-count":29,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2022,12]]}},"alternative-id":["5276"],"URL":"https:\/\/doi.org\/10.1186\/s12884-022-05276-9","relation":{},"ISSN":["1471-2393"],"issn-type":[{"value":"1471-2393","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,12,17]]},"assertion":[{"value":"25 August 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 December 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 December 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Written informed consent was obtained from all patients before treatment, and the patients consented to the use of their retrospective data in scientific publications. This study was approved by the Ethics Review Board of the Northwest Women\u2019s and Children\u2019s Hospital, Xi\u2019an, China (No. 2022007). All procedures performed in the study involving human participants were in accordance with the ethical standards of the institutional and\/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"946"}}